Observational study of azithromycin in hospitalized patients with COVID-19.

ABSTRACT:

Background

The rapid spread of the disease caused by the novel SARS-CoV-2 virus has led to the use of multiple therapeutic agents whose efficacy has not been previously demonstrated. The objective of this study was to analyze whether there is an association between the use of azithromycin and the evolution of the pulmonary disease or the time to discharge, in patients hospitalized with COVID-19.

Methods

This was an observational study on a cohort of 418 patients admitted to three regional hospitals in Catalonia, Spain. As primary outcomes, we studied the evolution of SAFI ratio (oxygen saturation/fraction of inspired oxygen) in the first 48 hours of treatment and the time to discharge. The results were compared between patients treated and untreated with the study drug throu

SUBMITTER: Rodriguez-Molinero A 

PROVIDER: S-EPMC7470304 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature